Characterization of Changes in Serum Anti-Glycan Antibodies in Crohn's Disease – a Longitudinal Analysis

• Florian Rieder ,

  * E-mail: florian.rieder@t-online.de

  Affiliations Department of Internal Medicine I, University of Regensburg, Regensburg, Germany, Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United Sates of America, Department of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio, United Sates of America

  ⨯
• Rocio Lopez,

  Affiliation Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, United Sates of America

  ⨯
• Andre Franke,

  Affiliation Institute of Clinical Molecular Biology and Department of General Internal Medicine, Christian-Albrechts-University, Kiel, Germany

  ⨯
• Alexandra Wolf,

  Affiliation Department of Internal Medicine I, University of Regensburg, Regensburg, Germany

  ⨯
• Stephan Schleder,

  Affiliation Department of Internal Medicine I, University of Regensburg, Regensburg, Germany

  ⨯
• Andrea Dirmeier,

  Affiliation Department of Internal Medicine I, University of Regensburg, Regensburg, Germany

  ⨯
• Anja Schirbel,

  Affiliation Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United Sates of America

  ⨯
• Philip Rosenstiel,

  Affiliation Institute of Clinical Molecular Biology and Department of General Internal Medicine, Christian-Albrechts-University, Kiel, Germany

  ⨯
• Nir Dotan,

  Affiliation Glycominds Ltd., Lod, Israel

  ⨯
• Stefan Schreiber,

  Affiliation Institute of Clinical Molecular Biology and Department of General Internal Medicine, Christian-Albrechts-University, Kiel, Germany

  ⨯
• Gerhard Rogler,

  Affiliation Departement of Internal Medicine, Clinic for Gastroenterology and Hepatology, University Hospital Zuerich, Zuerich, Switzerland

  ⨯
• Frank Klebl

  Affiliation Department of Internal Medicine I, University of Regensburg, Regensburg, Germany

  ⨯